News
Needham Reiterates Buy on Verrica Pharmaceuticals, Maintains $8 Price Target
10 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Verrica Pharmaceuticals' Lead Product, Ycanth, Has Received New Chemical Entity Status And A Listing In The Orange Book From The FDA, Providing A Minimum of Five Years Of Regulatory Exclusivity
26 Mar 24
News, Health Care, FDA, General
Needham Reiterates Buy on Verrica Pharmaceuticals, Maintains $8 Price Target
1 Mar 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Verrica Pharmaceuticals, Raises Price Target to $13
1 Mar 24
News, Price Target, Analyst Ratings
Verrica Pharmaceuticals Q4 EPS $(0.53), Inline, Sales $1.99M Beat $910.00K Estimate
29 Feb 24
Earnings, News
Earnings Scheduled For February 29, 2024
29 Feb 24
Earnings
Earnings Outlook For Verrica Pharmaceuticals
28 Feb 24
Earnings
Press releases
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
2 Apr 24
News, Press Releases
Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA
26 Mar 24
Press Releases
VERRICA PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA
8 Mar 24
Press Releases
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
29 Feb 24
Earnings, Press Releases
Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference
27 Feb 24
News, Press Releases
VERRICA PHARMACEUTICALS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA
23 Feb 24
Press Releases
Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024
22 Feb 24
News, Press Releases
VERRICA PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA
14 Feb 24
Press Releases
Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition
5 Feb 24
News, Legal, Press Releases
Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH™ from Centers for Medicare and Medicaid Services
29 Jan 24
Press Releases, General